Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,172,000
+$3,441,328 QoQ
Shares Held
88,110
+2.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#576
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Curi Capital, LLC holds $231,661,896 across 11 Drug Manufacturers - General names. ABBV ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,624 | $78,711,400 | |
| 2 | MRK |
Merck & Co., Inc.
|
375,369 | $48,234,916 | |
| 3 | AZN |
Astrazeneca PLC
|
119,992 | $22,752,882 | |
| 4 | JNJ |
Johnson & Johnson
|
88,578 | $22,496,153 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
88,110 | $22,172,000 | |
| 6 | NVS |
Novartis AG
|
114,209 | $17,898,833 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,608 | $7,404,533 | |
| 8 | AMGN |
Amgen Inc
|
19,312 | $6,993,261 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,172,000 | 88,110 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,730,672 | 86,122 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $19,043,955 | 83,347 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $19,520,905 | 84,309 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,590,845 | 78,606 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,574,357 | 36,151 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,010,989 | 50,709 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,300,951 | 52,162 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $8,863,982 | 51,679 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,331,079 | 56,733 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,680,003 | 49,558 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,524,846 | 50,482 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,600,018 | 48,987 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,596,849 | 47,668 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,554,944 | 46,748 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,737,745 | 42,752 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,013,943 | 52,324 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $8,479,649 | 52,308 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,097,938 | 52,422 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $6,009,653 | 55,712 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $6,137,753 | 54,490 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,905,024 | 54,565 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,942,860 | 55,463 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,904,266 | 67,408 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $7,017,120 | 71,472 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $5,366,442 | 70,435 | Shares | Other | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||